Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model

• Mehdi Najafzadeh,

  Affiliation Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Carlo A. Marra,

  Affiliations Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada

  ⨯
• Larry D. Lynd,

  Affiliations Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada

  ⨯
• Mohsen Sadatsafavi,

  Affiliations Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada

  ⨯
• J. Mark FitzGerald,

  Affiliations Division of Respiratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, The Institute for Heart and Lung Health (the UBC James Hogg Research Laboratories), Vancouver, British Columbia, Canada

  ⨯
• Bruce McManus,

  Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, and The Prevention of Organ Failure Center of Excellence, Vancouver, British Columbia, Canada, The Institute for Heart and Lung Health (the UBC James Hogg Research Laboratories), Vancouver, British Columbia, Canada

  ⨯
• Don Sin

  * E-mail: don.sin@hli.ubc.ca

  Affiliations Division of Respiratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, The Institute for Heart and Lung Health (the UBC James Hogg Research Laboratories), Vancouver, British Columbia, Canada

  ⨯